 |
|
LETTER TO THE EDITOR |
|
| Year : 2018 | Volume
: 13
| Issue : 4 | Page : 257 |
|
| Pattern of bone metastasis in patients with nonsmall cell lung cancer |
|
|
Kunihiko Miyazaki, Toshihiro Shiozawa, Hideyasu Yamada, Tomohiro Tamura, Hiroaki Satoh
Division of Respiratory Medicine, Mito Medical Center, University of Tsukuba-Mito Kyodo General Hospital, Ibaraki, Japan
| Date of Web Publication | 10-Oct-2018 |
Correspondence Address:
Dr. Hiroaki Satoh
Division of Respiratory Medicine, Mito Medical Center, University of Tsukuba-Mito Kyodo General Hospital, Ibaraki
Japan
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/atm.ATM_237_18
|
|
How to cite this article:
Miyazaki K, Shiozawa T, Yamada H, Tamura T, Satoh H. Pattern of bone metastasis in patients with nonsmall cell lung cancer. Ann Thorac Med 2018;13:257 |
Sir,
With great interest, we read the article by Jazieh et al. on the pattern of bone involvement, management, and outcomes in patients with nonsmall cell lung cancer (August issue 2018, Ann Thorac Med).[1] The results of this article were interesting and agreeable contents. We have also been interested in bone metastasis and reported some articles.[2],[3] We would like to ask the authors three questions. First, it is a question about the diagnosis of bone metastasis. The authors did not show the concrete number of patients how they diagnosed with bone scan, magnetic resonance, bone biopsy, or them. We do agree with the difficulty in recommending bone biopsy for unresectable lung cancer patients. Therefore, we agree with the diagnosis with images is realistic. If so, what is the optimal diagnostic method? In addition, please let us know how the authors differentiated diseases other than bone metastasis. Second, it is a question about the patients included in this study. The authors included 48 (18.5%) patients with stage I–III and 13 (5.1%) patients with unknown stage. Therefore, they included not a few patients without metastasis. We do wonder whether inclusion of these patients might be correct or not methodologically. Please explain the correctness of this inclusion. Third, it is a question about patients with liver and bone metastases at the same time. We would like to know whether metastasis in each organ was solitary or multiple one. Were there any other metastases organs in these patients? We do appreciate hearing from the authors whether the metastasis was dissemination to multiple organs or did the metastasis be limited to these two organs.
Financial support and sponsorship
Nil.
Conflicts of interest
There are no conflicts of interest.
 References | |  |
| 1. | Jazieh AM, AlSumai TS, Ali YZ, Sheblaq NR, Alkaiyat M. The pattern of bone involvement, management, and outcomes in patients with nonsmall cell lung cancer: A retrospective study. Ann Thorac Med 2018;13:150-5.  [ PUBMED] [Full text] |
| 2. | Tamura T, Kurishima K, Nakazawa K, Kagohashi K, Ishikawa H, Satoh H, et al. Specific organ metastases and survival in metastatic non-small-cell lung cancer. Mol Clin Oncol 2015;3:217-21. |
| 3. | Kagohashi K, Satoh H, Ishikawa H, Ohtsuka M, Sekizawa K. Bone metastasis as the first manifestation of lung cancer. Int J Clin Pract 2003;57:184-6. |
|
|
| This article has been cited by | | 1 |
Long Non-Coding RNA CRYBG3 Promotes Lung Cancer Metastasis via Activating the eEF1A1/MDM2/MTBP Axis |
|
| Anqing Wu, Jiaxin Tang, Ziyang Guo, Yingchu Dai, Jing Nie, Wentao Hu, Ningang Liu, Caiyong Ye, Shihong Li, Hailong Pei, Guangming Zhou | | International Journal of Molecular Sciences. 2021; 22(6): 3211 | | [Pubmed] | [DOI] | |
|
|
|
|
|
|
|
|
|
|
|
| Article Access Statistics | | | Viewed | 2288 | | | Printed | 70 | | | Emailed | 0 | | | PDF Downloaded | 238 | | | Comments | [Add] | | | Cited by others | 1 | | |
|
|
